BackAdc Therapeutics SA Overview

Adc Therapeutics SA Long Term Debt

Adc Therapeutics SA's long-term debt is $410M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$410.93M
255.07% YoYΔ $295.19M vs prior year quarter

Peer trimmed avg / median

Loading

Adc Therapeutics SA Long Term Debt History

Loading

Adc Therapeutics SA vs. peers: Long Term Debt Comparison

Loading

Adc Therapeutics SA Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Adc Therapeutics SA (ADCT) FAQ

As of the most recent data (June 2026), ADCT shows a long-term debt of $410M. That compares with $120M in the prior-year period — up 255.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADCT's long-term debt is now $410M (was $120M) — a 255.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Adc Therapeutics SA is outperforming or lagging.

Tracking ADCT's long-term debt over time shows whether Adc Therapeutics SA is scaling, shrinking, or reshaping that part of the business. The current reading is $410M That compares with $120M in the prior-year period — up 255.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Adc Therapeutics SA's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $410M) with ownership activity and broader fundamentals.

Adc Therapeutics SA's long-term debt is $410M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.